Recent Updates
Recently added Catalysts
VTRS Positive Sentiment

Viatris to Report Third Quarter 2024 Financial Results on November 7, 2024 Viatris Inc. (NASDAQ: VTRS) will report its third quarter 2024 financial results on Thursday, November 7, 2024, before the open of the U.S. financial ...

Key Takeaway: Viatris Inc. (NASDAQ: VTRS) is scheduled to report its third quarter 2024 financial results on November 7, 2024, ahead of the U.S. markets opening. CEO Scott A. Smith and executives will host a live webcast at 8:30 a.m. ET to discuss these results, which will be available both via a call and on the company’s investor website. This transparency reflects Viatris's commitment to keeping stakeholders informed about its performance.
Price reaction · baseline $11.66 (2024-09-13 close) · 2 other VTRS headline(s) in the window, move may be shared
day 0 close · peak
+1.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Viatris will report its financial results, indicating ongoing business activities.
  • The webcast will be accessible to both investors and the general public, promoting transparency.
  • The company’s extensive global reach and comprehensive portfolio enhance its market position.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+38%
120-day peak, hindsight
Typical move
1.6%
average across 12 past catalysts
Lead asset
Mylan's insulin glargine
Phase 3 · Type 1 Diabetes

Full Press Release Details

PITTSBURGH , Sept. 16 , 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS ) will report its third quarter 2024 financial results on Thursday, November 7, 2024 , before the open of the U.S. financial markets. Chief Executive Officer Scott A. Smith and other Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.
Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.
About Viatris Viatris Inc . (NASDAQ: VTRS ) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh , Shanghai and Hyderabad, India . Learn more at viatris.com and investor.viatris.com , and connect with us on LinkedIn , Instagram , YouTube and X (formerly Twitter).

About Viatris Inc.

Ticker Symbol: VTRS
Exchange: NASDAQ
Mission: Empower people worldwide to live healthier at every stage of life
Patient Reach: ~1 billion patients annually
Global Centers: Pittsburgh, Shanghai, Hyderabad

Frequently Asked Questions

When will Viatris report its third quarter financial results?

Viatris will report its third quarter 2024 financial results on November 7, 2024.

What time will the Viatris financial webcast begin?

The webcast will begin at 8:30 a.m. ET on November 7, 2024.

How can I access the Viatris financial results webcast?

You can access the webcast at investor.viatris.com or by calling specified numbers.

What is Viatris’ mission?

Viatris aims to empower people worldwide to live healthier at every stage of life.

Where is Viatris headquartered?

Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai, and Hyderabad.

Last updated: Sep 16, 2024